保德國際發展(00372.HK)料2020財年將錄得淨虧損
格隆匯5月15日丨保德國際發展(00372.HK)發佈公告,根據截至2020年3月31日止年度集團未經審核綜合管理賬目初步審閲及公司現時所得其他資料,與2019年財政年度的淨溢利相比,預期集團於2020年財政年度將錄得淨虧損。
與2019年財政年度相比,董事會認為該預期淨虧損主要歸因於集團於AFC Mercury Fund的投資於2020年財政年度按公允值計入損益的未變現虧損約為3.7億港元(屬非現金性質),而2019年財政年度相關未變現收益約為3.8億港元;及2020年財政年度集團於聯營公司保華集團有限公司的應占權益將錄得減值虧損約為3.5億港元,而2019年財政年度相關應占權益的減值虧損約為1億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.